Results 1 to 10 of about 1,803,893 (333)

Hepatocellular carcinoma‐infiltrating γδ T cells are functionally defected and allogenic Vδ2+ γδ T cell can be a promising complement

open access: yesClinical and Translational Medicine, 2022
In hepatocellular carcinoma (HCC), γδ T cells participate in mediating the anti‐tumour response and are linked with a positive prognosis. However, these cells can become pro‐tumoural in the tumour microenvironment (TME).
Wenjing He   +12 more
doaj   +3 more sources

Comparing Mouse and Human Tissue-Resident γδ T Cells

open access: yesFrontiers in Immunology, 2022
Circulating immune cell compartments have been extensively studied for decades, but limited access to peripheral tissue and cell yield have hampered our understanding of tissue-based immunity, especially in γδ T cells. γδ T cells are a unique subset of T
Guanyu Qu   +5 more
doaj   +2 more sources

Engineering γδ T Cells: Recognizing and Activating on Their Own Way

open access: yesFrontiers in Immunology, 2022
Adoptive cell therapy (ACT) with engineered T cells has emerged as a promising strategy for the treatment of malignant tumors. Among them, there is great interest in engineered γδ T cells for ACT.
Ruoyu Dong   +3 more
doaj   +2 more sources

Gamma-delta (γδ) T cells: friend or foe in cancer development?

open access: yesJournal of Translational Medicine, 2018
Background γδ T cells are a distinct subgroup of T cells containing T cell receptors (TCRs) γ and TCR δ chains with diverse structural and functional heterogeneity.
Yijing Zhao, Chao Niu, Jiuwei Cui
doaj   +2 more sources

Characterization of Stimulated γδ T Cells: Phenotypic Analysis and Implications for Allogeneic Cellular Immunotherapy [PDF]

open access: yesCells
Due to their anti-tumor activity and non-major histocompatibility complex (MHC) binding T cell receptor, γδ T cells are suitable candidates for allogeneic cellular immunotherapy in cancer.
Anna Bold   +5 more
doaj   +2 more sources

Fitness Training for γδ T cells in mouse and human atherosclerosis takes place in plaques and artery tertiary lymphoid organs [PDF]

open access: yesGenome Medicine
Background γδ T cells represent a heterogeneous family of innate-like lymphocytes with adaptive immunity features. Although abundant in barrier tissues such as skin and intestine, γδ T cells are rare in the cardiovascular system, which severely limits ...
Zhihua Wang   +20 more
doaj   +2 more sources

γδ T cells: origin and fate, subsets, diseases and immunotherapy

open access: yesSignal Transduction and Targeted Therapy, 2023
The intricacy of diseases, shaped by intrinsic processes like immune system exhaustion and hyperactivation, highlights the potential of immune renormalization as a promising strategy in disease treatment.
Yi Hu   +7 more
semanticscholar   +1 more source

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

open access: yesNature, 2023
DNA mismatch repair-deficient (MMR-d) cancers present an abundance of neoantigens that is thought to explain their exceptional responsiveness to immune checkpoint blockade (ICB)^ 1 , 2 .
Natasja L. de Vries   +20 more
semanticscholar   +1 more source

Ability of γδ T cells to modulate the Foxp3 T cell response is dependent on adenosine. [PDF]

open access: yesPLoS ONE, 2018
Whether γδ T cells inhibit or enhance the Foxp3 T cell response depends upon their activation status. The critical enhancing effector in the supernatant is adenosine.
Dongchun Liang   +6 more
doaj   +1 more source

γδ T Cells in Brain Homeostasis and Diseases

open access: yesFrontiers in Immunology, 2022
γδ T cells are a distinct subset of T cells expressing γδ T cell receptor (TCR) rather than αβTCR. Since their discovery, the critical roles of γδ T cells in multiple physiological systems and diseases have been investigated.
Jang Hyun Park, In Kang, Heung Kyu Lee
doaj   +1 more source

Home - About - Disclaimer - Privacy